DTL
OLMA icon

Dynamic Technology Lab’s Olema Pharmaceuticals OLMA Stock Holding History

Dynamic Technology Lab’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-19,894
Closed -$238K – 1241
2024
Q3 		$238K Buy
+19,894
New +$254K 0.03% 821
2022
Q3 		– Sell
-10,429
Closed -$42K – 1407
2022
Q2 		$42K Buy
+10,429
New +$33.1K ﹤0.01% 1034

Other funds holding OLMA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LMC
Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return

Dynamic Technology Lab's OLMA Position: Q4 2024 in Review

Dynamic Technology Lab sold out of Olema Pharmaceuticals (OLMA) in Q4 2024, closing a stake of 19,894 shares — an estimated $238K sold.

Dynamic Technology Lab first reported a position in OLMA in Q2 2022 and held it in 2 quarters. The position peaked at $238K in Q3 2024. 156 funds tracked by Wall St. Rank hold OLMA as of Q4 2024.

  • Dynamic Technology Lab reported no remaining Olema Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 19,894 Olema Pharmaceuticals shares in Q4 2024, an estimated $238K.
  • Dynamic Technology Lab first reported a position in Olema Pharmaceuticals in Q2 2022 and held it in 2 quarters.
  • Dynamic Technology Lab's Olema Pharmaceuticals position peaked at $238K in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q4 2024.

Based on Dynamic Technology Lab's 13F filing for Q4 2024, filed 13 Feb 2025.